Surmodics Appoints Andy LaFrence as Chief Financial Officer

Surmodics, Inc.

EDEN PRAIRIE, Minn.--(BUSINESS WIRE)--Dec. 21, 2012-- Surmodics, Inc. (Nasdaq:SRDX), a leading provider of surface modification and in vitro diagnostic technologies to the healthcare industries, today announced the appointment of Andy LaFrence as the company’s Vice President of Finance and Chief Financial Officer, effective February 12, 2013. He will lead all of the financial activities of Surmodics, including controlling, financial planning and analysis, treasury, tax, audit and investor relations.